Saturday May 26 | Flint Township/Swartz Creek Advance
Perrigo approved to market generic version of yeast infection fighter Gynazole
Perrigo Co. announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for butoconazole nitrate 2% vaginal cream.
Flint Township/Swartz Creek Advance
Perrigo's top brass to make presentations on the East and West Coasts
Joseph C. Papa, chairman, president and chief executive officer of the store-brand pharmaceuticals maker, is scheduled to present at the Jefferies Global Healthcare Conference on the morning of June 4 in New York City.
Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream
ALLEGAN, Mich., May 22, 2012 /PRNewswire/ -- Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for butoconazole nitrate 2% vaginal cream, the generic equivalent of Gynazole 1 . Perrigo was the first applicant to submit a substantially complete ANDA ... (more)
Perrigo Company Announces FDA Final Approval and Launch of Store...
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia /PRNewswire/ -- Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for ... (more)
Perrigo Announces FDA Final Approval and Launch of Store Brand OTC Lansoprazole 15mg Capsules
ALLEGAN, Mich., May 18, 2012 /PRNewswire/ -- Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for Lansoprazole capsules .
Perrigo ([[PRGO]] -0.2%) has received final FDA approval for its...
Perrigo has received final FDA approval for its abbreviated new drug application for Lansoprazole capsules for the treatment of frequent heartburn.
Perrigo Company to Present at the Bank of America Merrill Lynch 2012 Healthcare Conference
ALLEGAN, Mich., May 15, 2012 /PRNewswire/ -- Perrigo Company today announced that Perrigo Executive Vice President and Chief Financial Officer, Judy L. Brown, will present at the Bank of America Merrill Lynch Healthcare Conference on Tuesday, May 15, at 10:00 AM in Las Vegas, NV.
Stifel Nicolaus Starts Coverage on Perrigo
Perrigo opened at 99.91 on Tuesday. Perrigo has a 52-week low of $75.89 and a 52-week high of $108.60. The company has a market cap of $9.333 billion and a price-to-earnings ratio of 25.29. Perrigo last posted its quarterly earnings results on Tuesday, May 8th.
TEVA's Q1 Effect on Specialty Pharma
"The quarter was mixed with concerns linked to weak EU result, lack of guidance update and a combination of the two.
Perrigo Given "Buy" Rating at Auriga
Shares of Perrigo traded down 0.63% during mid-day trading on Wednesday, hitting $99.37. Perrigo has a one year low of $75.89 and a one year high of $108.60. The company has a market cap of $9.272 billion and a P/E ratio of 27.23. Perrigo last announced its earnings results on Tuesday, May 8th.
Stock in Tesla Motors, the electric-car company led by Elon Musk, fell to the lowest price in more than three months after Toyota said its RAV4 SUV with batteries and motor from Tesla costs twice as much as a gasoline version.
Earnings Beat at Perrigo - Analyst Blog
PRGO ) third quarter fiscal 2012 adjusted earnings of $1.41 handsomely beat the Zacks Consensus Estimate of $1.21 per share.
Active Stocks: GTx, Vitamin Shoppe, Synch Tech, Perrigo May 8th
GTx, Inc. : GTx announced that the FDA removed its Full Clinical Hold on the company's Investigational New Drug application for Capesaris following the review by the FDA of the Company's complete response and its new Phase II clinical protocol.
Perrigo 3Q profit up, outlook raised
ALLEGAN, Mich. — Perrigo Co., which makes store brand, over-the-counter drugs and infant formulas, said Tuesday that its fiscal third-quarter profit rose from a year ago as new product launches boosted sales.
Dun & Bradstreet, Mako, Perrigo, Synchronoss: U.S. Equity Movers
Shares of the following companies are having unusual moves in U.S. trading. Stock symbols are in parentheses, and prices are as of 10:29 a.m. in New York.
Tale Of 2 Public Companies: Taro Pharma And Perrigo
Taro Pharma And Perrigo : Both the companies are public. Shares of both the companies trade in reputed US exchanges.
Flint Township/Swartz Creek Advance
Allegan-based Perrigo Co. to release quarterly earnings report on May 8
Perrigo Co. will release financial results for the third quarter of its 2012 fiscal year at 8 a.m. on Tuesday, May 8. Joseph C. Papa, chairman, president and chief executive officer of the store brand products maker, will host a conference call with financial analysts and others at 10 a.m. the same day.
Flint Township/Swartz Creek Advance
Three are promoted at Perrigo Co. in Allegan
Ken Moench has been promoted as QA Label Specification Reviewer for the company's Quality Assurance team.